Affiliation:
1. Birmingham Food Council and visiting Professional Fellow at the Crisis Management Centre, Aston Business School, Birmingham, UK
2. General Practice at the University of Birmingham
3. Public Health at the University of Wolverhampton and Immediate Past President of the Faculty of Public Health
Abstract
Abstract
The impact of drug-foods (tobacco and cane sugar, cocoa and caffeine) and the consequences of their production on the health of both public and planet are wide ranging and increasing from obesity to pressure on water supply. The world’s food system is dominated by a small number of global corporations making and promoting drug-foods in myriad forms. The use of sugar-substitute non-sugar sweeteners, and their design of products, are specifically formulated to be ‘moreish’, to stimulate pleasure responses above and beyond the natural pleasure of eating. In the UK we can identify these foods, and the corporations that make them, since Value Added Tax (VAT) is applied. We suggest that, for food and drink upon which UK VAT is levied, advertising and product placement should be prohibited and controls put on branding and packaging. We further suggest action is taken to: (i) restrain the activities of the companies making these products, (ii) prohibit their sponsorship and/or partnership with government bodies such as schools and NHS, (iii) ensure these corporations pay the full fiscal and environmental costs of drug-foods. Our urgent challenge is to act against the sociopathic power of such corporations, for the public health and that of the planet.
Publisher
Oxford University Press (OUP)
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference41 articles.
1. Gaining weight by “going diet”? Artificial sweeteners and the neurobiology of sugar cravings;Yang;J Biol Med,2010
2. Artificial sweeteners as a cause of obesity: weight gain mechanisms and current evidence;Cabral;Health,2018
3. Supra- addictive effects of combining fat and carbohydrate on food reward;DiFeliceantonio;Cell Metab,2018